These data strongly support targeting the DNA binding of HIF-1 and other key transcription factors via redox inhibition of APE1/Ref-1 in combination with blockade of another aspect of HIF-1 signaling in order to more effectively shut down the HIF pathway, resulting in increased tumor cell death. Here, HIF1A is linked to neoplasm.